Science Explorer Back to mapMap
Discussion
Researcher · Dokuz Eylül University · Türkiye

Barış Akıncı

Barış Akıncı publishes mostly in Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery, on topics such as Nuclear Structure and Function, Diabetes and associated disorders and HIV-related health complications and treatments.

ORCID 0000-0002-8634-4845 OpenAlex
World rank
#3,794,732
of 7,710,434 ranked researchers
Rank in Türkiye
#27,875
of 117,622
Works
251
Citations
3.2k
Citations per work
12.7
h-index
33
i10-index 93Top 12% in Molecular Biology
Barış Akıncı

What does Barış Akıncı research?

Barış Akıncı's work is mostly in Medicine (33%), Biochemistry, Genetics and Molecular Biology (30%).

Everything else: 94 works · 37.5% of their workHealth Sciences: 82 works · 32.8% of their workMedicine: 82 works · 32.8% of their workEndocrinology, Diabetes and Metabolism: 39 works · 15.5% of their workSurgery: 18 works · 7.0% of their workOncology: 15 works · 6.0% of their workEpidemiology: 11 works · 4.3% of their workLife Sciences: 75 works · 29.7% of their workBiochemistry, Genetics and Molecular Biology: 75 works · 29.7% of their workMolecular Biology: 59 works · 23.4% of their workGenetics: 16 works · 6.3% of their workTHEIR WORKBarış Akıncı251works
Life Sciences30%Health Sciences33%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else9437.5%
    1. Medicine8232.8%
    1. Biochemistry, Genetics and Molecular Biology7529.7%
  1. 1Molecular Biology23% of their works
  2. 2Endocrinology, Diabetes and Metabolism16% of their works
  3. 3Surgery7% of their works
  4. 4Genetics6% of their works
  5. 5Oncology6% of their works
  6. 6Epidemiology4% of their works

Research topics

Which keywords describe Barış Akıncı's research?

The keywords of their largest research topics: Nuclear Pore Complex, Nucleocytoplasmic Transport, Cardiovascular Disease, Insulin Resistance, Inflammation, Metabolic Syndrome, Obesity and Genetics.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Nuclear Pore Complex1051 topic
  2. Nucleocytoplasmic Transport1051 topic
  3. Cardiovascular Disease623 topics
  4. Insulin Resistance623 topics
  5. Inflammation432 topics
  6. Metabolic Syndrome382 topics
  7. Obesity382 topics
  8. Genetics321 topic
  9. Type 1 Diabetes321 topic
  10. Antiretroviral Therapy241 topic
  11. HIV Infection241 topic
  12. Adipokines191 topic
  13. Adipose Tissue191 topic
  14. Diabetes191 topic
  15. Glucose Metabolism191 topic
  16. Chaperone181 topic
  17. Clusterin181 topic
  18. Caveolae171 topic
  19. Caveolin171 topic
  20. Differentiated Thyroid Cancer151 topic
  21. Thyroid Nodules151 topic

Where does Barış Akıncı work?

Barış Akıncı's main affiliation in the publication record is Dokuz Eylül University, Türkiye.

How many publications and citations does Barış Akıncı have?

OpenAlex counts 251 works and 3,186 citations for Barış Akıncı, an h-index of 33, ranking #3,794,732 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Barış Akıncı. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.